Literature DB >> 15930599

Addendum to the IPEMB code of practice for the determination of absorbed dose for x-rays below 300 kV generating potential (0.035 mm Al-4 mm Cu HVL).

R J Aukett1, J E Burns, A G Greener, R M Harrison, C Moretti, A E Nahum, K E Rosser.   

Abstract

This addendum to the code of practice for the determination of absorbed dose for x-rays below 300 kV has recently been approved by the IPEM and introduces three main changes: (i) Due to a lack of available data the original code recommended a value of unity for k(ch) in the very-low-energy range (0.035-1.0 mm Al HVL). A single table of k(ch) values, ranging from 1.01 to 1.07, applicable to both designated chamber types is now presented. (ii) For medium-energy x-rays (0.5-4 mm Cu HVL) methods are given to determine the absorbed dose to water either at 2 cm depth or at the surface of a phantom depending on clinical needs. Determination of the dose at the phantom surface is derived from an in-air measurement and by extending the low-energy range up to 4 mm Cu HVL. Relevant backscatter factors and ratios of mass energy absorption coefficients are given in the addendum. (iii) Relative dosimetry: although not normally forming part of a dosimetry code of practice a brief review of the current literature on this topic has been added as an appendix. This encompasses advice on techniques for measuring depth doses, applicator factors for small field sizes, dose fall off with increasing SSD and choice of appropriate phantom materials and ionization chambers.

Entities:  

Mesh:

Year:  2005        PMID: 15930599     DOI: 10.1088/0031-9155/50/12/001

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  17 in total

1.  Analysis of regional radiotherapy dosimetry audit data and recommendations for future audits.

Authors:  A Palmer; B Mzenda; J Kearton; R Wills
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

2.  Acceptance, commissioning and clinical use of the WOmed T-200 kilovoltage X-ray therapy unit.

Authors:  Maria M Aspradakis; Paolo Zucchetti
Journal:  Br J Radiol       Date:  2015-07-30       Impact factor: 3.039

3.  A national dosimetry audit of intraoperative radiotherapy.

Authors:  D J Eaton; B Earner; P Faulkner; N Dancer
Journal:  Br J Radiol       Date:  2013-10-16       Impact factor: 3.039

Review 4.  Electronic brachytherapy--current status and future directions.

Authors:  D J Eaton
Journal:  Br J Radiol       Date:  2015-03-06       Impact factor: 3.039

5.  Current status of kilovoltage (kV) radiotherapy in the UK: installed equipment, clinical workload, physics quality control and radiation dosimetry.

Authors:  Antony L Palmer; Michael Pearson; Paul Whittard; Katie E McHugh; David J Eaton
Journal:  Br J Radiol       Date:  2016-10-12       Impact factor: 3.039

6.  Measurement of patient imaging dose for real-time kilovoltage x-ray intrafraction tumour position monitoring in prostate patients.

Authors:  James K Crocker; Jin Aun Ng; Paul J Keall; Jeremy T Booth
Journal:  Phys Med Biol       Date:  2012-04-20       Impact factor: 3.609

7.  Estimation of effective imaging dose for kilovoltage intratreatment monitoring of the prostate position during cancer radiotherapy.

Authors:  J A Ng; J Booth; P Poulsen; Z Kuncic; P J Keall
Journal:  Phys Med Biol       Date:  2013-08-12       Impact factor: 3.609

8.  Energy and dose dependence of GafChromic EBT3-V3 film across a wide energy range.

Authors:  Sarah Bassi; Donal Cummins; Patrick McCavana
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-09

9.  Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy.

Authors:  Rebecca Lamb; Marco Fiorillo; Amy Chadwick; Bela Ozsvari; Kimberly J Reeves; Duncan L Smith; Robert B Clarke; Sacha J Howell; Anna Rita Cappello; Ubaldo E Martinez-Outschoorn; Maria Peiris-Pagès; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2015-06-10

10.  Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer.

Authors:  E M Donovan; H James; M Bonora; J R Yarnold; P M Evans
Journal:  Med Phys       Date:  2012-10       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.